BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response - Concepedia

Concepedia

Publication | Open Access

BET protein targeting suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer and elicits anti-tumor immune response

DOI Full Paper Access

58

Citations

40

References

2019

Year

Guillaume P. Andrieu, Jordan Shafran, Charlotte Smith, Anna C. Belkina, Allison N. Casey, Naser Jafari, Gerald V. Denis

Bet ProteinBreast OncologyCancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint InhibitorBreast CancerTriple-negative Breast CancerPd-1/pd-l1 PathwayImmunotherapyMedicineCell Biology

References

	Year	Citations

Page 1

Page 1